NL-OMON24759招募中不适用
A 12-week single blind randomized controlled trial to evaluate the efficacy and safety of methotrexate (MTX) versus azathioprine (AZA) treatment in adult patients with chronic severe atopic dermatitis (AD) followed by a 5 year follow up study.
Academic Medical Center, department of Dermatology0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 42
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subject is 18 years of age or older at baseline; both genders;
- •2. Subject has a diagnosis of AD for at least 6 months based on millennium criteria (with or without IgE) and UK-criteria;
排除标准
- •1. Subject is pregnant, nursing, or planning pregnancy (men and women) while enrolled in the study and until 3 months after discontinuation of the study;
- •2. Subject has used any investigational drug within the previous 4 weeks or 5 times the half-life of the investigational agent prior to the first administration of study agent, whichever is longer;
研究者
相似试验
已完成
不适用
A 52 week double blind randomized controlled trial comparing the effect of Rosiglitazone versus Placebo on the prevention of progression of atherosclerosis in high risk patients without diabetes.Metabolic SyndromeNL-OMON24183MC116
已完成
不适用
The effects of an online decision aid on self-testing for cholesterol and diabetes.self-test, diabetes, cardiovascular risk, cholesterol.NL-OMON25594Maastricht University700
尚未招募
不适用
A clinical trial to study the effect of changes in the strength of pulse to predict the onset of caudal block which is a method of giving pain relief in childreCTRI/2021/06/034021Institute of Anaesthesiology and Critical care
进行中（未招募）
不适用
A 12-week clinical double-blind, randomised study of vitamin D versus placebo in patients with chronic kidney disease stage 3-4 (CHICK).Chronic renal failure, stage 3-4MedDRA version: 14.0Level: PTClassification code 10038444Term: Renal failure chronicSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2011-002586-38-SERenapharma AB100
已完成
不适用
The effectiveness and safety of a herbal formulation for the management of osteoarthritis of the kneeACTRN12619000320156ICM Health Research Institute, Western Sydney University75